Target intelligence / Profile preview

Clostridioides difficile spore antigens (C. difficile spore antigens)

Target
C. difficile spore antigens
Molecular classification
Bacterial surface protein, Antigen, Glycoprotein
01

Overview

Clostridioides difficile spore antigens are a complex array of proteins and glycoproteins located on the outermost layers of the bacterial spore, specifically the spore coat and the exosporium (Paredes-Sabja, D., et al., 2014). These antigens, including BclA1, CdeC, CdeM, and various Cot proteins, are essential for the spore's structural integrity and its ability to survive extreme environmental conditions and gastric acid (Calderón-Romero, P., et al., 2018). In the context of infection, these surface components facilitate the initial adherence of spores to the host's intestinal epithelium, a critical step for colonization (Barra-Carrasco, J., & Paredes-Sabja, D., 2014). Furthermore, specific antigens are involved in sensing environmental cues that trigger germination into the vegetative, toxin-producing state that causes clinical disease (Zhu, D., et al., 2018). Because spores are resistant to standard antibiotics and are responsible for high rates of disease recurrence, these antigens have become primary targets for the development of vaccines and monoclonal antibodies. Therapeutic strategies focusing on these antigens aim to enhance the host's immune clearance of spores via opsonophagocytosis or to physically prevent the spores from adhering and germinating within the gut (Paredes-Sabja, D., et al., 2014).

Other names
C. diff spore proteinsClostridium difficile spore surface antigensExosporium proteinsSpore coat proteinsC. difficile spore-surface proteins
02

Mechanism of action

Induction of opsonophagocytic antibodies to facilitate immune-mediated clearance of spores, blocking of spore-host cell interactions to prevent colonization, and interference with the signaling pathways required for spore germination (Paredes-Sabja, D., et al., 2014; Zhu, D., et al., 2018).

03

Biological functions

Bacterial germinationCell adhesionEnvironmental resistanceSporulationImmune evasion
04

Disease associations

Clostridioides difficile infectionInfectionColitisDiarrhea
05

Safety considerations

Antigenic variation across different ribotypesPotential for incomplete protection if germination is not fully inhibitedChallenge of achieving high mucosal antibody titers (Zhu, D., et al., 2018)
06

Interacting drugs

VLA1701 (investigational vaccine)

4 more in the full profile.

07

Biomarkers

Anti-spore IgG antibody titerAnti-spore IgA antibody titerFecal spore count

Beyond the preview

Go deeper on Clostridioides difficile spore antigens (C. difficile spore antigens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridioides difficile spore antigens (C. difficile spore antigens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call